These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 24947406

  • 1. Early inflammatory response in epithelial ovarian tumor cyst fluids.
    Kristjánsdóttir B, Partheen K, Fung ET, Yip C, Levan K, Sundfeldt K.
    Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
    Podzielinski I, Saunders BA, Kimbler KD, Branscum AJ, Fung ET, DePriest PD, van Nagell JR, Ueland FR, Baron AT.
    Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer.
    Kristjansdottir B, Levan K, Partheen K, Sundfeldt K.
    Gynecol Oncol; 2013 Oct; 131(1):52-8. PubMed ID: 23891789
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor in adnexal masses.
    Demirkiran F, Kumbak B, Bese T, Arvas M, Benian A, Aydin S, Uzun H, Sanioglu C, Aydinli K, Kösebay D.
    Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
    [Abstract] [Full Text] [Related]

  • 5. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
    Candido Dos Reis F, Moreira de Andrade J, Bighetti S.
    Gynecol Obstet Invest; 2002 Oct; 54(3):132-6. PubMed ID: 12571433
    [Abstract] [Full Text] [Related]

  • 6. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P, Åkesson A, Hedenfalk I, Malander S, Borgfeldt C.
    PLoS One; 2020 Oct; 15(10):e0240418. PubMed ID: 33075095
    [Abstract] [Full Text] [Related]

  • 7. Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.
    Miyagi E, Maruyama Y, Mogami T, Numazaki R, Ikeda A, Yamamoto H, Hirahara F.
    Int J Clin Oncol; 2017 Feb; 22(1):118-125. PubMed ID: 27623814
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
    Kolwijck E, Span PN, Thomas CM, Bulten J, Sweep FC, Massuger LF.
    Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.
    Lane D, Matte I, Garde-Granger P, Laplante C, Carignan A, Rancourt C, Piché A.
    BMC Cancer; 2015 Jul 01; 15():492. PubMed ID: 26122176
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study.
    Mahyuddin AP, Liu L, Zhao C, Kothandaraman N, Salto-Tellez M, Pang B, Lim D, Annalamai L, Chan J, Lim T, Biswas A, Rice G, Razvi K, Choolani M.
    BJOG; 2018 Mar 01; 125(4):421-431. PubMed ID: 28755436
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
    Hazelton D, Nicosia RF, Nicosia SV.
    Clin Cancer Res; 1999 Apr 01; 5(4):823-9. PubMed ID: 10213218
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass.
    Lokich E, Palisoul M, Romano N, Craig Miller M, Robison K, Stuckey A, DiSilvestro P, Mathews C, Granai CO, Lambert-Messerlian G, Moore RG.
    Gynecol Oncol; 2015 Nov 01; 139(2):248-52. PubMed ID: 26364809
    [Abstract] [Full Text] [Related]

  • 15. Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.
    Sasaki A, Akita K, Ito F, Mori T, Kitawaki J, Nakada H.
    Int J Cancer; 2015 Apr 15; 136(8):1985-90. PubMed ID: 25197000
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.
    Karasik A, Menczer J, Pariente C, Kanety H.
    J Clin Endocrinol Metab; 1994 Feb 15; 78(2):271-6. PubMed ID: 7508947
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin is detectable in the ascitic fluid in patients with ovarian tumors.
    Stefanovic V, Pakarinen P, Alfthan H, Stenman UH, Leminen A, Pociuviene J, Riska A, Loukovaara M.
    Int J Gynecol Cancer; 2012 Nov 15; 22(9):1470-3. PubMed ID: 23027039
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J, Tang L, Chen Y, Duan Z, Xiao L, Li W, Liu X, Shen L.
    Hum Pathol; 2015 Sep 15; 46(9):1331-40. PubMed ID: 26193797
    [Abstract] [Full Text] [Related]

  • 19. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL, Mhawech-Fauceglia PY, Ji L, Skeate JG, Brand HE, Lawrenson K, Walia S, Chiriva-Internati M, Groshen S, Roman LD, Kast WM, Da Silva DM.
    BMC Cancer; 2018 Oct 11; 18(1):970. PubMed ID: 30309325
    [Abstract] [Full Text] [Related]

  • 20. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
    Saied EM, El-Etreby NM.
    Ann Diagn Pathol; 2017 Apr 11; 27():62-68. PubMed ID: 28325363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.